Filip Bondy wrote a story today about the likelihood that growth hormone would be more expensive and more difficult to obtain for parents of children with growth-related disorders as a result of a Congressional bill that would reclassify human growth hormone as a controlled substance (”Littlest victims of an HGH bill,” March 17). Here’s the problem: [...]
